Valeo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2016
Period Ending	Feb '26 Feb 10, 2026	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	2018 - 2016
Market Capitalization	0	10	40	54	44	-	Upgrade
Market Cap Growth	-100.00%	-74.23%	-25.13%	21.74%	-	-	Upgrade
Enterprise Value	46	52	64	55	47	-	Upgrade
Last Close Price	0.00	0.10	0.49	0.68	0.69	-	Upgrade
PS Ratio	-	0.27	1.97	4.90	7.85	-	Upgrade
PB Ratio	-	-0.36	-3.07	32.38	19.10	-	Upgrade
P/TBV Ratio	-	-	-	-	67.22	-	Upgrade
EV/Sales Ratio	1.19	1.33	3.13	5.00	8.42	-	Upgrade
Debt / Equity Ratio	-1.12	-1.63	-3.44	3.74	1.06	-45.50	Upgrade
Net Debt / Equity Ratio	-1.01	-1.44	-2.18	2.74	0.14	-30.27	Upgrade
Net Debt / EBITDA Ratio	-4.51	-4.47	-2.42	-0.51	-0.11	-0.18	Upgrade
Net Debt / FCF Ratio	-15.81	-3.60	-1.35	-0.43	-0.08	-0.29	Upgrade
Asset Turnover	1.37	1.08	0.70	0.85	0.89	1.43	Upgrade
Inventory Turnover	4.22	3.89	2.18	2.20	8.45	15.78	Upgrade
Quick Ratio	0.17	0.69	1.82	0.25	0.95	0.21	Upgrade
Current Ratio	0.27	1.25	2.64	0.81	1.26	0.37	Upgrade
Return on Equity (ROE)	-	-	-	-555.76%	-312.50%	-	Upgrade
Return on Assets (ROA)	-26.07%	-19.18%	-27.03%	-44.47%	-31.66%	-50.82%	Upgrade
Return on Capital Employed (ROCE)	43.00%	-72.90%	-39.90%	-199.80%	-63.50%	-281.00%	Upgrade
Earnings Yield	-23487830.30%	-193.51%	-47.02%	-21.41%	-8.12%	-	Upgrade
FCF Yield	-2941097.98%	-112.54%	-52.71%	-19.88%	-9.14%	-	Upgrade
Buyback Yield / Dilution	-5.42%	-6.50%	-15.63%	-20.76%	-16.78%	-39.09%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.